US-based medical device company Spineology has introduced the OptiMesh Align implant, designed to enhance patient-specific spinal surgery outcomes.
Building on the existing OptiMesh technology, Align enables real-time, in-situ expansion for both anterior and posterior implants, achieving a customised lordotic shape up to 20°. This is accomplished through a small insertion profile that expands significantly, allowing corrections typically uncommon with minimally invasive posterior spine methods.
OptiMesh employs a biologics-based expansion strategy to address challenges and minimise point-loading often associated with mechanical implant technology. The new Align version is crafted to generate distraction forces and endplate conformance, offering strength and stability to restore disc height and create a solid fusion scaffold.
This innovation supports alignment objectives through Spineology’s Conform and Expand flexible mesh interbody technology, potentially setting new standards in lumbar interbody fusion.
Spineology CEO Brian Snider said: “Sagittal alignment is widely considered one of the key correlative indicators to achieving long term clinical success for spine patients. The OptiMesh technology remains the only conforming expandable implant that offers a personalized solution for each patient.
“With the addition of the lordotic capabilities of the Align implant, our portfolio provides more options to achieve the clinical requirements of surgery.”
Spineology focuses on developing spinal expandable implants tailored to patient needs. OptiMesh, which is its flagship product, is claimed to be the sole conforming patient-specific spinal implant in the market with investigational device exemption (IDE) level data, distinguishing it from traditional fusion techniques.
The implant allows surgeons to achieve better outcomes with minimal tissue disruption, aligning with Spineology’s commitment to patient-centred care by providing solutions aimed at reducing pain and promoting recovery.
